Abstract |
High-dose ionizing irradiation (IR) results in direct tumor cell death and augments tumor-specific immunity, which enhances tumor control both locally and distantly. Unfortunately, local relapses often occur following IR treatment, indicating that IR-induced responses are inadequate to maintain antitumor immunity. Therapeutic blockade of the T cell negative regulator programmed death-ligand 1 (PD-L1, also called B7-H1) can enhance T cell effector function when PD-L1 is expressed in chronically inflamed tissues and tumors. Here, we demonstrate that PD-L1 was upregulated in the tumor microenvironment after IR. Administration of anti-PD-L1 enhanced the efficacy of IR through a cytotoxic T cell-dependent mechanism. Concomitant with IR-mediated tumor regression, we observed that IR and anti-PD-L1 synergistically reduced the local accumulation of tumor-infiltrating myeloid-derived suppressor cells (MDSCs), which suppress T cells and alter the tumor immune microenvironment. Furthermore, activation of cytotoxic T cells with combination therapy mediated the reduction of MDSCs in tumors through the cytotoxic actions of TNF. Our data provide evidence for a close interaction between IR, T cells, and the PD-L1/PD-1 axis and establish a basis for the rational design of combination therapy with immune modulators and radiotherapy.
|
Authors | Liufu Deng, Hua Liang, Byron Burnette, Michael Beckett, Thomas Darga, Ralph R Weichselbaum, Yang-Xin Fu |
Journal | The Journal of clinical investigation
(J Clin Invest)
Vol. 124
Issue 2
Pg. 687-95
(Feb 2014)
ISSN: 1558-8238 [Electronic] United States |
PMID | 24382348
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- B7-H1 Antigen
- Cd274 protein, mouse
|
Topics |
- Animals
- Apoptosis
- B7-H1 Antigen
(metabolism)
- CD4-Positive T-Lymphocytes
(cytology)
- CD8-Positive T-Lymphocytes
(cytology)
- Cell Line, Tumor
- Flow Cytometry
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Microscopy, Fluorescence
- Myeloid Cells
(cytology)
- Neoplasm Transplantation
- Neoplasms, Experimental
(drug therapy, immunology, radiotherapy)
- Radiation, Ionizing
- Time Factors
- Tumor Microenvironment
|